# Frequency Electronics Inc: Form 10-Q for the period ended Oct 31, 2019

- Company: [Frequency Electronics Inc](/companies/feim.md) (CIK 39020)
- Form: 10-Q
- Filed: 2019-12-16
- Accepted by EDGAR: Dec 16, 2019, 15:11 ET
- Period: 2019-10-31
- Accession: 0001185185-19-001720
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/39020/000118518519001720/freqelec20191031_10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/39020/000118518519001720/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2019-10-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2019-08-01 to 2019-10-31 | $9.1m | us-gaap:Revenues |
| Revenue | 6 months, 2019-05-01 to 2019-10-31 | $21.6m | us-gaap:Revenues |
| Cost of revenue | 3 months, 2019-08-01 to 2019-10-31 | $10.3m | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months, 2019-05-01 to 2019-10-31 | $18.9m | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2019-08-01 to 2019-10-31 | −$1.2m | us-gaap:GrossProfit |
| Gross profit | 6 months, 2019-05-01 to 2019-10-31 | $2.8m | us-gaap:GrossProfit |
| Research and development | 3 months, 2019-08-01 to 2019-10-31 | $1.4m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months, 2019-05-01 to 2019-10-31 | $3.7m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2019-08-01 to 2019-10-31 | $2.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months, 2019-05-01 to 2019-10-31 | $4.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2019-08-01 to 2019-10-31 | −$4.9m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2019-05-01 to 2019-10-31 | −$5.7m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2019-08-01 to 2019-10-31 | $25.0k | us-gaap:InterestExpense |
| Interest expense | 6 months, 2019-05-01 to 2019-10-31 | $50.0k | us-gaap:InterestExpense |
| Income tax | 3 months, 2019-08-01 to 2019-10-31 | $9.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2019-05-01 to 2019-10-31 | $29.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2019-08-01 to 2019-10-31 | −$4.9m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2019-05-01 to 2019-10-31 | −$5.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2019-08-01 to 2019-10-31 | −$0.54 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2019-05-01 to 2019-10-31 | −$0.61 | us-gaap:EarningsPerShareDiluted |
| Diluted shares (weighted) | 3 months, 2019-08-01 to 2019-10-31 | 9,072,141 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2019-05-01 to 2019-10-31 | 9,036,732 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2019-05-01 to 2019-10-31 | $180.0k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months, 2019-05-01 to 2019-10-31 | $1.3m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2019-10-31 | $2.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2019-10-31 | $49.1m | us-gaap:AssetsCurrent |
| Total assets | at 2019-10-31 | $91.9m | us-gaap:Assets |
| Current liabilities | at 2019-10-31 | $8.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2019-10-31 | $33.8m | us-gaap:Liabilities |
| Shareholders' equity | at 2019-10-31 | $58.2m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 23,743 characters.

*“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995:*

The statements in this quarterly report on Form 10-Q regarding future earnings and operations and other statements relating to the future constitute “forward-looking” statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1933 or the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The words “believe,” “may,” “will,” “could,” “should,” “would,” “anticipate,” “estimate,” “expect,” “project,” “intend,” “objective,” “seek,” “strive,” “might,” “likely result,” “build,” “grow,” “plan,” “goal,” “expand,” “position,” or similar words, or the negatives of these words, or similar terminology, identify forward-looking statements. All statements by the Company that address activities, events or developments that the Company expects or anticipates will occur in the future, including all statements by the Company regarding its expected financial position, revenues, cash flows and other operating results, business position, legal proceedings or similar matters, are forward-looking statements. These statements are based on assumptions that the Company believes are reasonable, but are subject to a wide range of risks and uncertainties, and a number of factors could cause the Company’s actual results to differ materially from those expressed in the forward-looking statements referred to above. Factors that would cause or contribute to such differences include, but are not limited to, continued acceptance of the Company’s products in the marketplace, competitive factors, new products and technological changes, product prices and raw material costs, dependence upon third-party vendors, competitive developments, changes in manufacturing and transportation costs, changes in contractual terms, the availability of capital, and other risks detailed in the Company’s periodic report filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which relate only to events as of the date on which the statements are made and which reflect management’s analysis, judgments, belief, or expectation only as of such date. Any and all of the forward-looking statements contained in this Form 10-Q and any other public statements by the Company or its management may turn out to be incorrect. The Company expressly disclaims any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law.

### Critical Accounting Policies and Estimates

The Company’s significant accounting policies are described in Note 1 to the consolidated financial statements included in the 2019 Form 10-K. The Company believes its most critical accounting policies to be the recognition of revenue and costs on production contracts, income taxes, and the valuation of inventory. Each of these areas requires the Company to make use of reasoned estimates including estimating the cost to complete a contract, the realizable value of its inventory and the market value of its products. Changes in estimates can have a material impact on the Company’s financial position and results of operations. The Company’s significant accounting policies did not change during the six and three months ended October 31, 2019, except for those impacted by the newly adopted accounting standard regarding leases.

#### Revenue Recognition

Revenue is recognized when a performance obligation is satisfied, when the expected goods or services are transferred to the customer, in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. A performance obligation is a distinct product or service that is transferred to the customer’s control based on the contract. The transaction price is allocated to each performance obligation and is recognized as revenue upon satisfaction of that performance obligation. The Company derives revenue either as (i) units with specifications and frequencies that can be used by multiple customers (POT) or (ii) units with specific specifications and frequencies that are used by a specific customer or for government end use (POC).

Revenues under larger, long-term contracts which generally require billings based on achievement of milestones rather than delivery of product, are reported in operating results using the POC method. On fixed-price contracts, which are typical for commercial and U.S. Government satellite programs and other long-term U.S. Government projects, and which require initial design and development of the product, revenue is recognized on the cost-to-cost method. Under this method, revenue is recorded based upon the ratio that incurred costs bear to total estimated contract costs with related cost of sales recorded as the costs are incurred. Each month management reviews estimated contract costs through a process of aggregating actual costs incurred and estimating additional costs to completion based upon the current available information and status of the contract. In situations where the estimated costs to complete a project are revised, revenue earned to date is adjusted on a prospective basis. Provisions for the full amount of anticipated losses on contracts are made in the period in which they become determinable.

On production-type orders, revenue is recorded as units are delivered with the related cost of sales recognized on each shipment based upon a percentage of estimated final program costs. Changes in job performance on long-term contracts and production-type orders may result in revisions to costs and income and are recognized in the period in which revisions are determined to be required. Provisions for anticipated losses on customer orders are made in the period in which they become determinable.

For customer orders in the Company’s FEI-Zyfer segment or smaller contracts or orders in the FEI-NY segment, sales of products and services to customers are reported in operating results based upon (i) shipment of the product or (ii) performance of the services pursuant to terms of the customer order which then transfers control of the performance obligation to the customer. When payment is contingent upon customer acceptance of the installed product, revenue is deferred until such installation completed and acceptance is received.

#### Costs and Expenses

Contract costs include all direct material costs, direct labor costs, manufacturing overhead and other direct costs related to contract performance. Selling, general and administrative costs are expensed as incurred, with the exception of sales commissions with an amortization period of greater than one year which are amortized over the length of the contract in relation to the adoption of ASU 2014-09.

#### Inventory

In accordance with industry practice, inventoried costs contain amounts relating to contracts and programs with long production cycles, a portion of which will not be realized within one year. Inventory write-downs are established for slow-moving, obsolete items and costs incurred on programs for which production-level orders cannot be determined as probable. Such write-downs are based upon management’s experience and expectations for future business. Any changes arising from revised expectations are reflected in cost of revenues in the period the revision is made.

#### Marketable Securities

All of the Company’s investments in marketable securities are Level 1 securities which trade on public markets and have current prices that are readily available. In general, investments in fixed income securities are limited to the commercial paper of financially sound corporations or the bonds and shorter-term notes of U.S. Government agencies. Although the value of such investments may fluctuate significantly based on economic factors, the Company’s own financial strength enables it to wait for the securities to either recover their value or to mature such that any interim unrealized gains or losses are deemed to be temporary.

### RESULTS OF OPERATIONS

The table below sets forth for the six and three months ended October 31, 2019 and 2018, respectively, the percentage of consolidated revenues represented by certain items in the Company’s condensed consolidated statements of operations or notes to the condensed consolidated financial statements:

| Revenues | Six months Periods ended October 31, 2019 | 2018 | Three months 2019 | 2018 |
| --- | ---: | ---: | ---: | ---: |
| FEI-NY | 77.6% | 79.1% | 85.7% | 80.3% |
| FEI-Zyfer | 26.3 | 22.0 | 22.0 | 20.9 |
| Less intersegment revenues | (3.9) | (1.1) | (7.7) | (1.2) |
|  | 100.0 | 100.0 | 100.0 | 100.0 |
| Cost of revenues | 87.2 | 64.2 | 113.0 | 66.9 |
| Gross margin | 12.8 | 35.8 | (13.0) | 33.1 |
| Selling and administrative expenses | 21.9 | 22.4 | 25.2 | 21.8 |
| Research and development expenses | 17.3 | 14.1 | 16.0 | 13.2 |
| Operating loss | (26.4) | (0.7) | (54.2) | (1.9) |
| Other income (loss), net | 1.1 | 1.2 | 0.3 | 2.7 |
| Provision (benefit) for income taxes | 0.1 | (0.1) | 0.1 | (0.2) |
| Net (loss) income | (25.4)% | 0.6% | (54.0)% | 1.0% |

17

### Revenues

| Segment | Six months Periods ended October 31, 2019 | 2018 | Change |  | Three months 2019 | 2018 | Change |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| FEI-NY | $16,794 | $18,322 | $(1,528) | (8.3)% | $7,784 | $9,745 | $(1,961) | (20.1)% |
| FEI-Zyfer | 5,701 | 5,103 | 598 | 11.7 | 2,000 | 2,542 | (542) | (21.3) |
| Intersegment revenues | (854) | (272) | (582) | NM | (697) | (145) | (552) | NM |
|  | $21,641 | $23,153 | $(1,512) | (6.5)% | $9,087 | $12,142 | $(3,055) | (25.2)% |

For the six months ended October 31, 2019, revenues from commercial and U.S. Government satellite programs decreased approximately $1.9 million as compared to the same period of the previous fiscal year. For the six months ended October 31, 2019 and the six months ended October 31, 2018, revenue from commercial and U.S. Government satellite programs accounted for approximately 44% and 49%, respectively, of consolidated revenues. Revenues on these contracts are recognized primarily under the POC method. Revenues from the satellite market are recorded in the FEI-NY segment. Revenues from non-space U.S. Government/Department of Defense (“DOD”) customers, which are recorded in both the FEI-NY and FEI-Zyfer segments, decreased $1.4 million as compared to the same period of fiscal 2019, and accounted for approximately 42% of consolidated revenues during the six months ended October 31, 2019 as compared to approximately 45% during this same period in fiscal 2019. Other commercial and industrial revenues for the six months ended October 31, 2019 accounted for approximately 14% of consolidated revenues as compared to 6% in the same period in fiscal 2019. Intersegment revenues are eliminated in consolidation.

For the three months ended October 31, 2019 revenues from commercial and U.S. Government satellite programs decreased approximately $200,000 as compared to the same period of fiscal 2019. For the three months ended October 31, 2019, revenues from commercial and U.S. Government satellite programs accounted for approximately 61% of consolidated revenues compared to approximately 48% during this same period in fiscal 2019. Revenues from non-space U.S. Government/DOD customers, which are recorded in both the FEI-NY and FEI-Zyfer segments, decreased $3.4 million as compared to the same period of fiscal 2019, and accounted for approximately 25% of consolidated revenues during the three months ended October 31, 2019 as compared to approximately 46% during this same period in fiscal 2019. Other commercial and industrial revenues for the three months ended October 31, 2019 and the three months ended October 31, 2018 accounted for approximately 14% and 6%, respectively of consolidated revenues.

Revenue for both the six and three months ended October 31, 2019, compared to the same period of the prior fiscal year, were impacted by timing slippage of anticipated contract awards.

### Gross Margin

|  | Six months Periods ended October 31, 2019 | 2018 | Change |  | Three months 2019 | 2018 | Change |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | --- |
|  | $2,771 | $8,293 | $(5,522) | (66.6)% | $(1,182) | $4,019 | $(5,201) | NM |
| GM Rate | 12.8% | 35.8% |  |  | (13.0)% | 33.1% |  |  |

For the six and three month periods ended October 31, 2019, gross margin and GM Rate decreased as compared to the same periods in fiscal 2019. The GM rate was impacted by increases in engineering costs incurred on several programs, which are in the development phase and which encountered unanticipated technical challenges related to customer driven system packaging and environmental requirements for state-of-the-art performance demands.

### Selling and Administrative Expenses

*Periods ended October 31,*

| Six months 2019 | 2018 | Change |  | Three months 2019 | 2018 | Change |  |
| ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| $4,743 | $5,182 | $(439) | (8.5)% | $2,290 | $2,642 | $(352) | (13.3)% |

For the six months ended October 31, 2019 and 2018, selling and administrative (“SG&A”) expenses were approximately 22%, of consolidated revenues for both periods. For the three months ended October 31, 2019 and 2018, SG&A expenses were approximately 25% and 22% respectively, of consolidated revenues. While SG&A expenses remained even as a percentage of consolidated revenue, during the six and three months ended October 31, 2019, as compared to the six and three months ended October 31, 2018, the actual dollars expenditures decreased by $439,000 and $352,000 respectively.

### Research and Development Expense

*Periods ended October 31,*

| Six months 2019 | 2018 | Change |  | Three months 2019 | 2018 | Change |  |
| ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| $3,731 | $3,257 | $474 | 14.6% | $1,450 | $1,607 | $(157) | (9.8)% |

Research and development (“R&D”) expenditures represent investments intended to keep the Company’s products at the leading edge of time and frequency technology and enhance future competitiveness. The R&D rate for the six months ended October 31, 2019 was 17% of sales compared to 14% of sales for the same period of the previous fiscal year. The R&D rate for the three months ended October 31, 2019 was 16% of sales as compared to 13% of sales for the same period of the previous fiscal year. The Company expects to maintain a high level of internally funded activity related to R&D through the balance of the current year and beyond to address new large opportunities, which it plans to pursue.

### Operating Loss

| Six months Periods ended October 31, 2019 | 2018 | Change |  | Three months 2019 | 2018 | Change |  |
| ---: | ---: | ---: | --- | ---: | ---: | ---: | --- |
| $(5,703) | $(146) | $(5,557) | NM | $(4,922) | $(230) | $(4,692) | NM |

The increase in operating loss for both the six months and three months ended October 31, 2019, as compared to the respective periods in fiscal 2019 was attributable largely to the increased engineering costs described previously. The increased costs affect revenue, gross margin and operating loss.

### Other Income (Expense)

|  | Six months Periods ended October 31, 2019 | 2018 | Change |  | Three months 2019 | 2018 | Change |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Investment income | $224 | $189 | $35 | 18.5% | $45 | $144 | $(99) | (68.8)% |
| Interest expense | (50) | (34) | (16) | 47.1% | (25) | (17) | (8) | 47.1% |
| Other income (expense), net | 58 | 121 | (63) | (52.1)% | 2 | 195 | (193) | (99.0)% |
|  | $232 | $276 | $(44) | (15.9)% | $22 | $322 | $(300) | (93.2)% |

Investment income is derived primarily from the Company’s holdings of marketable securities. Earnings on securities may vary based on fluctuating interest rates, dividend payout levels, and the timing of purchases, sales, redemptions or maturities of securities. For the six-month period ended October 31, 2019 investment income includes a $125,000 dividend from Morion, compared to a $105,000 dividend from Morion in the same period in fiscal 2019.

### Income Tax Provision (Benefit)

*Periods ended October 31,*

| Six months 2019 | 2018 | Change |  | Three months 2019 | 2018 | Change |  |
| ---: | ---: | ---: | --- | ---: | ---: | ---: | --- |
| $29 | $(23) | $52 | NM | $9 | $(30) | $39 | NM |
| Effective tax rate on pre-tax book (loss) income: |  |  |  |  |  |  |  |
| (0.5)% | (17.7)% |  |  | (0.2)% | (32.6)% |  |  |

The estimated annual effective tax rate for the fiscal year ending April 30, 2020 is 0%. This calculation reflects estimated income tax expense (benefit) based on our current year forecasted earnings, which is offset by a corresponding change in the current year valuation allowance. As of October 31, 2019, and April 30, 2019, the Company maintained a full valuation allowance against its deferred tax assets.

For the six months ended October 31, 2019, the Company recorded a discrete income tax provision of $28,900, which primarily consisted of an accrual of interest for unrecognized tax benefits. For the six months ended October 31, 2018, the Company recorded an income tax benefit of $(22,600), which includes a discrete income tax provision of $36,700.

For the three months ended October 31, 2019, the Company recorded a discrete income tax provision of $9,400, which primarily consisted of an accrual of interest for unrecognized tax benefits. For the three months ended October 31, 2018, the Company recorded an income tax benefit of $(29,700), which includes a discrete income tax provision of $18,400.

The effective tax rate for the six months ended October 31, 2019 was an income tax provision of (0.5) % on a pretax loss of $5,808,000 compared to an income tax benefit of (17.7) % on pretax income of $130,000 in the comparable prior year period. The effective tax rate for the six months ended October 31, 2019 differs from the U.S. statutory rate of 21% primarily due to a discrete income tax provision related to the accrual of interest for unrecognized tax benefits and domestic losses for which the Company is not recognizing an income tax benefit.

The effective tax rate for the three months ended October 31, 2019 was an income tax provision of (0.2) % on a pretax loss of $5,237,000 compared to an income tax benefit of (32.6) % on pretax income of $92,000 in the comparable prior year period. The effective tax rate for the three months ended October 31, 2019 differs from the U.S. statutory rate of 21% primarily due to a discrete income tax provision related to the accrual of interest for unrecognized tax benefits and domestic losses for which the Company is not recognizing an income tax benefit.

LIQUIDITY AND CAPITAL RESOURCES

The Company’s balance sheet continues to reflect a strong working capital position of $40.7 million at October 31, 2019 and $46.9 million at April 30, 2019. Included in working capital at October 31, 2019 and April 30 2019, is $11.0 million and $11.9 million, respectively, consisting of cash, cash equivalents, and marketable securities. The Company’s current ratio at October 31, 2019 was 5.9 to 1.

Cash provided by operations for the six months ended October 31, 2019 was $180,000 compared to $1.1 million of cash used in operations in the comparable fiscal 2019 period. The increase cash flow in the fiscal 2020 period resulted primarily from a decrease in accounts receivable balances. For the six-month periods ended October 31, 2019 and 2018, the Company incurred approximately $3.9 million and $2.2 million, respectively, of non-cash operating expenses including ROU assets and liabilities for leases, loss provision accrual, depreciation and amortization, inventory reserve adjustments, and accruals for employee benefit programs.

Net cash used in investing activities for the six months ended October 31, 2019 was $1.3 million compared to $2.6 million for the six months ended October 31, 2018. During the fiscal 2020 period, marketable securities were sold or redeemed in the amount of $2.5 million compared to $947,000 of such redemptions during the comparable fiscal 2019 period. During the six months ended October 31, 2019 approximately $2.5 million of marketable securities were purchased compared to $2.2 million for the same period of fiscal 2019. The Company acquired property, plant and equipment in the amount of approximately $1.3 million for the six-month periods ended October 31, 2019 and 2018. The Company may continue to invest in cash equivalents as dictated by its investment strategy.

There was no cash provided by financing activities for either the six months ended October 31, 2019 or 2018.

The Company has been authorized by its Board of Directors to repurchase up to $5 million worth of shares of its common stock when appropriate opportunities arise. As of October 31, 2019, the Company has repurchased approximately $4 million of its common stock out of the $5 million authorization. For the six months ended October 31, 2019 and 2018, there were no repurchases of shares.

The Company will continue to expend resources to develop, improve and acquire products for space applications, guidance and targeting systems, and communication systems which management believes will result in future growth and profitability. The Company anticipates securing additional customer funding for a portion of its R&D activities and will allocate internal funds depending on market conditions and identification of new opportunities. The Company expects internally generated cash will be adequate to fund these R&D efforts. The Company may also pursue acquisitions to expand its range of products and may use internally generated cash and external funding in connection with such acquisitions.

As of October 31, 2019, the Company’s consolidated funded backlog was approximately $40 million compared to $37 million at April 30, 2019, the end of fiscal 2019. Approximately 81% of this backlog is expected to be realized in the next twelve months. As of October 31, 2019, there were no amounts included in backlog under cost-plus fixed-fee (“CPFF”) contracts that have not been funded. The Company excludes from backlog any contracts or awards for which it has not received authorization to proceed. On fixed price contracts, the Company excludes any unfunded portion. Over time, as partially funded contracts become fully funded, the Company will add the additional funding to its backlog. The backlog is subject to change for various reasons, including possible cancellation of orders, change orders, terms of the contracts and other factors beyond the Company’s control. Accordingly, the backlog is not necessarily indicative of the revenues or profits (losses) which may be realized when the results of such contracts are reported.

The Company believes that its liquidity is adequate to meet its operating and investment needs through at least December 17, 2020 and the foreseeable future.

The Company’s international business may be subject to changes where contracts are delineated in currencies other than the US Dollar.

### Off-Balance Sheet Arrangements

The Company does not have any off-balance sheet arrangements, other than operating leases, that have or are reasonably likely to have a current or future effect on the Company’s financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

## Controls and procedures

As filed, 1,735 characters.

Disclosure Controls and Procedures. The Company’s management, with the participation of the Company’s chief executive officer and chief financial officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this report. Based on their evaluation, the Company’s chief executive officer and chief financial officer have concluded that, as of October 31, 2019, the Company’s disclosure controls and procedures were effective to ensure that information relating to the Company, including its consolidated subsidiaries, required to be included in its reports that it filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission rules and forms.

There are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of the controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable assurance of achieving their control objectives.

Changes in Internal Control Over Financial Reporting. There were no changes in the Company’s internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the fiscal quarter ended October 31, 2019 to which this report relates that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

Filed Dec 16, 2019.
Source: SEC EDGAR, the filing index for accession 0001185185-19-001720. Last ingested by Listed: Nov 5, 2026, 18:05 ET. No prices; not investment advice.
